16-04-2019
109
Global Gene Therapy for CNS Disorders Market Growth (Status and Outlook) 2019-2024
Gene Therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

According to this study, over the next five years the Gene Therapy for CNS Disorders market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Gene Therapy for CNS Disorders business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Gene Therapy for CNS Disorders market by product type, application, key companies and key regions.

This study considers the Gene Therapy for CNS Disorders value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Ex Vivo
In Vivo
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Gilead (Kite Pharma)
Amgen (BioVex)
Novartis
Roche (Spark Therapeutics)
Bluebird Bio
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gene Therapy for CNS Disorders market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gene Therapy for CNS Disorders market by identifying its various subsegments.
Focuses on the key global Gene Therapy for CNS Disorders players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gene Therapy for CNS Disorders with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Gene Therapy for CNS Disorders submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Gene Therapy for CNS Disorders Market Growth (Status and Outlook) 2019-2024


Table of Contents

2019-2024 Global Gene Therapy for CNS Disorders Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapy for CNS Disorders Market Size 2014-2024
2.1.2 Gene Therapy for CNS Disorders Market Size CAGR by Region
2.2 Gene Therapy for CNS Disorders Segment by Type
2.2.1 Ex Vivo
2.2.2 In Vivo
2.3 Gene Therapy for CNS Disorders Market Size by Type
2.3.1 Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019)
2.3.2 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type (2014-2019)
2.4 Gene Therapy for CNS Disorders Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Gene Therapy for CNS Disorders Market Size by Application
2.5.1 Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019)
2.5.2 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Application (2014-2019)

3 Global Gene Therapy for CNS Disorders by Players
3.1 Global Gene Therapy for CNS Disorders Market Size Market Share by Players
3.1.1 Global Gene Therapy for CNS Disorders Market Size by Players (2017-2019)
3.1.2 Global Gene Therapy for CNS Disorders Market Size Market Share by Players (2017-2019)
3.2 Global Gene Therapy for CNS Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Gene Therapy for CNS Disorders by Regions
4.1 Gene Therapy for CNS Disorders Market Size by Regions
4.2 Americas Gene Therapy for CNS Disorders Market Size Growth
4.3 APAC Gene Therapy for CNS Disorders Market Size Growth
4.4 Europe Gene Therapy for CNS Disorders Market Size Growth
4.5 Middle East & Africa Gene Therapy for CNS Disorders Market Size Growth

5 Americas
5.1 Americas Gene Therapy for CNS Disorders Market Size by Countries
5.2 Americas Gene Therapy for CNS Disorders Market Size by Type
5.3 Americas Gene Therapy for CNS Disorders Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Gene Therapy for CNS Disorders Market Size by Countries
6.2 APAC Gene Therapy for CNS Disorders Market Size by Type
6.3 APAC Gene Therapy for CNS Disorders Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Gene Therapy for CNS Disorders by Countries
7.2 Europe Gene Therapy for CNS Disorders Market Size by Type
7.3 Europe Gene Therapy for CNS Disorders Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Gene Therapy for CNS Disorders by Countries
8.2 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type
8.3 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Gene Therapy for CNS Disorders Market Forecast
10.1 Global Gene Therapy for CNS Disorders Market Size Forecast (2019-2024)
10.2 Global Gene Therapy for CNS Disorders Forecast by Regions
10.2.1 Global Gene Therapy for CNS Disorders Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Gene Therapy for CNS Disorders Forecast by Type
10.8 Global Gene Therapy for CNS Disorders Forecast by Application

11 Key Players Analysis
11.1 Gilead (Kite Pharma)
11.1.1 Company Details
11.1.2 Gene Therapy for CNS Disorders Product Offered
11.1.3 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Gilead (Kite Pharma) News
11.2 Amgen (BioVex)
11.2.1 Company Details
11.2.2 Gene Therapy for CNS Disorders Product Offered
11.2.3 Amgen (BioVex) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Amgen (BioVex) News
11.3 Novartis
11.3.1 Company Details
11.3.2 Gene Therapy for CNS Disorders Product Offered
11.3.3 Novartis Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Novartis News
11.4 Roche (Spark Therapeutics)
11.4.1 Company Details
11.4.2 Gene Therapy for CNS Disorders Product Offered
11.4.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Roche (Spark Therapeutics) News
11.5 Bluebird Bio
11.5.1 Company Details
11.5.2 Gene Therapy for CNS Disorders Product Offered
11.5.3 Bluebird Bio Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Bluebird Bio News
...

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Gene Therapy for CNS Disorders
Figure Gene Therapy for CNS Disorders Report Years Considered
Figure Market Research Methodology
Figure Global Gene Therapy for CNS Disorders Market Size Growth Rate 2014-2024 ($ Millions)
Table Gene Therapy for CNS Disorders Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of Ex Vivo
Table Major Players of In Vivo
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019)
Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019)
Figure Global Ex Vivo Market Size Growth Rate
Figure Global In Vivo Market Size Growth Rate
Figure Gene Therapy for CNS Disorders Consumed in Hospitals
Figure Global Gene Therapy for CNS Disorders Market: Hospitals (2014-2019) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Gene Therapy for CNS Disorders Consumed in Clinics
Figure Global Gene Therapy for CNS Disorders Market: Clinics (2014-2019) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Gene Therapy for CNS Disorders Consumed in Others
Figure Global Gene Therapy for CNS Disorders Market: Others (2014-2019) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size by Application (2014-2019) ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019)
Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019)
Figure Global Gene Therapy for CNS Disorders Market Size in Hospitals Growth Rate
Figure Global Gene Therapy for CNS Disorders Market Size in Clinics Growth Rate
Figure Global Gene Therapy for CNS Disorders Market Size in Others Growth Rate
Table Global Gene Therapy for CNS Disorders Revenue by Players (2017-2019) ($ Millions)
Table Global Gene Therapy for CNS Disorders Revenue Market Share by Players (2017-2019)
Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Players in 2018
Table Global Gene Therapy for CNS Disorders Key Players Head office and Products Offered
Table Gene Therapy for CNS Disorders Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Gene Therapy for CNS Disorders Market Size by Regions 2014-2019 ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size Market Share by Regions 2014-2019
Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Regions 2014-2019
Figure Americas Gene Therapy for CNS Disorders Market Size 2014-2019 ($ Millions)
Figure APAC Gene Therapy for CNS Disorders Market Size 2014-2019 ($ Millions)
Figure Europe Gene Therapy for CNS Disorders Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Gene Therapy for CNS Disorders Market Size 2014-2019 ($ Millions)
Table Americas Gene Therapy for CNS Disorders Market Size by Countries (2014-2019) ($ Millions)
Table Americas Gene Therapy for CNS Disorders Market Size Market Share by Countries (2014-2019)
Figure Americas Gene Therapy for CNS Disorders Market Size Market Share by Countries in 2018
Table Americas Gene Therapy for CNS Disorders Market Size by Type (2014-2019) ($ Millions)
Table Americas Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019)
Figure Americas Gene Therapy for CNS Disorders Market Size Market Share by Type in 2018
Table Americas Gene Therapy for CNS Disorders Market Size by Application (2014-2019) ($ Millions)
Table Americas Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019)
Figure Americas Gene Therapy for CNS Disorders Market Size Market Share by Application in 2018
Figure United States Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Canada Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Table APAC Gene Therapy for CNS Disorders Market Size by Countries (2014-2019) ($ Millions)
Table APAC Gene Therapy for CNS Disorders Market Size Market Share by Countries (2014-2019)
Figure APAC Gene Therapy for CNS Disorders Market Size Market Share by Countries in 2018
Table APAC Gene Therapy for CNS Disorders Market Size by Type (2014-2019) ($ Millions)
Table APAC Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019)
Figure APAC Gene Therapy for CNS Disorders Market Size Market Share by Type in 2018
Table APAC Gene Therapy for CNS Disorders Market Size by Application (2014-2019) ($ Millions)
Table APAC Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019)
Figure APAC Gene Therapy for CNS Disorders Market Size Market Share by Application in 2018
Figure China Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Japan Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Korea Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure India Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Australia Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Table Europe Gene Therapy for CNS Disorders Market Size by Countries (2014-2019) ($ Millions)
Table Europe Gene Therapy for CNS Disorders Market Size Market Share by Countries (2014-2019)
Figure Europe Gene Therapy for CNS Disorders Market Size Market Share by Countries in 2018
Table Europe Gene Therapy for CNS Disorders Market Size by Type (2014-2019) ($ Millions)
Table Europe Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019)
Figure Europe Gene Therapy for CNS Disorders Market Size Market Share by Type in 2018
Table Europe Gene Therapy for CNS Disorders Market Size by Application (2014-2019) ($ Millions)
Table Europe Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019)
Figure Europe Gene Therapy for CNS Disorders Market Size Market Share by Application in 2018
Figure Germany Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure France Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure UK Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Italy Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Russia Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Spain Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Gene Therapy for CNS Disorders Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Countries in 2018
Table Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Type in 2018
Table Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Application in 2018
Figure Egypt Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Israel Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Gene Therapy for CNS Disorders Market Size Growth 2014-2019 ($ Millions)
Figure Global Gene Therapy for CNS Disorders arket Size Forecast (2019-2024) ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Regions
Figure Americas Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure APAC Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Europe Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure United States Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Canada Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Mexico Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Brazil Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure China Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Japan Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Korea Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure India Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Australia Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Germany Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure France Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure UK Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Italy Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Russia Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Spain Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Egypt Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure South Africa Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Israel Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure Turkey Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Figure GCC Countries Gene Therapy for CNS Disorders Market Size 2019-2024 ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Type (2019-2024)
Table Global Gene Therapy for CNS Disorders Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Application (2019-2024)
Table Gilead (Kite Pharma) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gilead (Kite Pharma) Gene Therapy for CNS Disorders Revenue and Gross Margin (2017-2019)
Figure Gilead (Kite Pharma) Gene Therapy for CNS Disorders Market Share (2017-2019)
Table Amgen (BioVex) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen (BioVex) Gene Therapy for CNS Disorders Revenue and Gross Margin (2017-2019)
Figure Amgen (BioVex) Gene Therapy for CNS Disorders Market Share (2017-2019)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Gene Therapy for CNS Disorders Revenue and Gross Margin (2017-2019)
Figure Novartis Gene Therapy for CNS Disorders Market Share (2017-2019)
Table Roche (Spark Therapeutics) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Revenue and Gross Margin (2017-2019)
Figure Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Market Share (2017-2019)
Table Bluebird Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bluebird Bio Gene Therapy for CNS Disorders Revenue and Gross Margin (2017-2019)
Figure Bluebird Bio Gene Therapy for CNS Disorders Market Share (2017-2019)

Enquiry Before Buying

*

*
*
*
*
*

Request Sample


*

*
*
*
*
*